THYMIC CARCINOMA
Clinical trials for THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug combo shows promise for tough cancers
Disease control CompletedThis early-phase trial tested a combination of two drugs—pembrolizumab (an immunotherapy) and nintedanib (a drug that blocks blood vessel growth)—in 196 adults with advanced solid tumors that had worsened after standard treatment. The main goal was to find the safest dose of nint…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Rare cancer survival predictor developed
Knowledge-focused CompletedThis study looked at 156 patients with thymic carcinoma, a rare and aggressive chest cancer. Researchers created a tool called a nomogram that uses patient data to predict how long someone might live after diagnosis. The tool was tested on three groups of patients and showed prom…
Matched conditions: THYMIC CARCINOMA
Phase: NA • Sponsor: Weijie Ye • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:33 UTC